Hideki Amuro

2.4k citations

41 papers · 1.7k indexed · 1 hit paper · h-index 16

Impact in

Immunology top 2%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Rheumatology top 1%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies

Papers in

Rheumatology 23
- Rheumatoid Arthritis Research and Therapies 20
- Systemic Lupus Erythematosus Research 10
Immunology 19
- Immune Cell Function and Interaction 8
- Biosimilars and Bioanalytical Methods 8
- T-cell and B-cell Immunology 5
- Immunotherapy and Immune Responses 3

Co-authors: Tomoki� Ito Shirou Fukuhara Stephan Meller Roberto Lande Roland L. Bassett Loredana Frasca Curdin Conrad Valeria Riccieri
Journals: Arthritis Research & Therapy (7 papers)Modern Rheumatology (6 papers)Annals of the Rheumatic Diseases (6 papers)Lara D. Veeken (2 papers)PLoS ONE (2 papers)
Partner nations: Japan United States

In The Last Decade

Hideki Amuro

41 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus 2011 · 999 citations

Peers

Countries citing papers authored by Hideki Amuro

Since Specialization

Citations

This map shows the geographic impact of Hideki Amuro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Amuro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Amuro more than expected).

Fields of papers citing papers by Hideki Amuro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Amuro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Amuro. The network helps show where Hideki Amuro may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hideki Amuro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hideki Amuro Line = papers co-authored together Hideki Amuro links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study Lara D. Veeken ·Yoichi Nakayama, Ryu Watanabe, Wataru Yamamoto, Kosuke Ebina, Tôru Hirano, Takuya Kotani, Hideyuki Shiba, Masaki Katayama, Yonsu Son, Hideki Amuro, Akira Ōnishi, Sadao Jinno, Ryota Hara, Kosaku Murakami, Koichi Murata, Hiromu Ito, Masao Tanaka, Shuichi Matsuda, Akio Morinobu, Motomu Hashimoto	2023	5
2	Comparative effectiveness of biological disease-modifying antirheumatic drugs and Janus kinase inhibitor monotherapy in rheumatoid arthritis Lara D. Veeken ·Akira Ōnishi, Li Zengrui, Wataru Yamamoto, Ryu Watanabe, Ryota Hara, Masaki Katayama, Yasutaka Okita, Yuichi Maeda, Hideki Amuro, Yonsu Son, B. Kitchen, Kenichiro Hata, Motomu Hashimoto, Jun Saegusa, Akio Morinobu	2023	3
3	Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study International Journal of Molecular Sciences ·Hideyuki Shiba, Takuya Kotani, Koji Nagai, Robert. Compositeur Smith, Wataru Yamamoto, B. Kitchen, Yumiko Wada, V. K. Wadhwa, Estéfan Baleta López, Yo Ueda, Akira Ōnishi, Koichi Murata, Hideki Amuro, Yonsu Son, Ryota Hara, Tôru Hirano, Kosuke Ebina, Masaki Katayama, Motomu Hashimoto, Tohru Takeuchi	2023	4
4	AB0407 IMPACT OF SEROPOSITIVITY ON DRUG RETENTION OF BIOLOGICS AND JAK INHIBITORS -THE ANSWER COHORT STUDY Annals of the Rheumatic Diseases ·Yuki Etani, Kosuke Ebina, Yasutaka Okita, Yuichi Maeda, 周海岩, Akira Ōnishi, A. Betti, T. Okano, Kunihiro Nishimura, B. Kitchen, Hideyuki Shiba, Hideki Amuro, Yonsu Son, M. Kynclova, Ryota Hara, Wataru Yamamoto, Atsushi Kumanogoh, Seiji Okada	2023	1
5	Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study Clinical Rheumatology ·Kosuke Ebina, Tôru Hirano, Yuichi Maeda, Wataru Yamamoto, Motomu Hashimoto, Koichi Murata, Akira Ōnishi, Sadao Jinno, Ryota Hara, Yonsu Son, Hideki Amuro, Tohru Takeuchi, B. Kitchen, Masaki Katayama, Keiichi Yamamoto, Makoto Hirao, Yasutaka Okita, Atsushi Kumanogoh, Ken Nakata	2021	16
6	Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study Arthritis Research & Therapy ·Sadao Jinno, Akira Ōnishi, Maureen Dubreuil, Motomu Hashimoto, Wataru Yamamoto, Koichi Murata, Tohru Takeuchi, Takuya Kotani, Yuichi Maeda, Kosuke Ebina, Yonsu Son, Hideki Amuro, Ryota Hara, Masaki Katayama, Jun Saegusa	2021	12
7	Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study Rheumatology International ·Yuichi Maeda, Tôru Hirano, Kosuke Ebina, Ryota Hara, Motomu Hashimoto, Wataru Yamamoto, Kosaku Murakami, Takuya Kotani, Kenichiro Hata, Yonsu Son, Hideki Amuro, Akira Ōnishi, Sadao Jinno, Masaki Katayama, Atsushi Kumanogoh	2021	1
8	THU0174 ANTI-IL-6 RECEPTOR ANTIBODY AMELIORATES DISEASE ACTIVITY OF RHEUMATOID ARTHRITIS PATIENTS WITH KNEE JOINT INVOLVEMENT -ANSWER COHORT STUDY- Annals of the Rheumatic Diseases ·Yuichi Maeda, Tôru Hirano, Ryota Hara, Kosuke Ebina, Motomu Hashimoto, Wataru Yamamoto, Kosaku Murakami, Takuya Kotani, Kenichiro Hata, Yonsu Son, Hideki Amuro, Akira Ōnishi, Annisaa Novieningtyas, Masaki Katayama, Atsushi Kumanogoh	2020	1
9	Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study- Clinical Rheumatology ·Kosuke Ebina, Tôru Hirano, Yuichi Maeda, Wataru Yamamoto, Motomu Hashimoto, Koichi Murata, Tohru Takeuchi, Koji Nagai, Yonsu Son, Hideki Amuro, Akira Ōnishi, Sadao Jinno, Ryota Hara, Masaki Katayama, Keiichi Yamamoto, Atsushi Kumanogoh, Makoto Hirao	2020	14
10	Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study Rheumatology International ·Sadao Jinno, Akira Ōnishi, Maureen Dubreuil, Kengo Akashi, Motomu Hashimoto, Wataru Yamamoto, Koichi Murata, Tohru Takeuchi, Takuya Kotani, Yuichi Maeda, Kosuke Ebina, Yonsu Son, Hideki Amuro, Ryota Hara, Masaki Katayama, Jun Saegusa, Akio Morinobu	2020	15
11	The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study Rheumatology International ·Koichi Murata, Motomu Hashimoto, Wataru Yamamoto, Yonsu Son, Hideki Amuro, Koji Nagai, Tohru Takeuchi, Masaki Katayama, Yuichi Maeda, Kosuke Ebina, Ryota Hara, Sadao Jinno, Akira Ōnishi, Kosaku Murakami, Masao Tanaka, Hiromu Ito, Tsuneyo Mimori, Shuichi Matsuda	2019	6
12	Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study Arthritis Research & Therapy ·Kosuke Ebina, Motomu Hashimoto, Wataru Yamamoto, Tôru Hirano, Ryota Hara, Masaki Katayama, Akira Ōnishi, Koji Nagai, Yonsu Son, Hideki Amuro, Keiichi Yamamoto, Yuichi Maeda, Koichi Murata, Sadao Jinno, Tohru Takeuchi, Makoto Hirao, Atsushi Kumanogoh, Hideki Yoshikawa	2019	39
13	Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study Arthritis Research & Therapy ·Motomu Hashimoto, Moritoshi Furu, Adelina Birceanu, Arzt u. Zahnarzt, Ryota Hara, Masaki Katayama, Akira Ohnishi, Kengo Akashi, Shuzo Yoshida, Koji Nagai, Yonsu Son, Hideki Amuro, Tôru Hirano, Kosuke Ebina, Ryuji Uozumi, Hiromu Ito, Masao Tanaka, Koichiro Ohmura, Takao Fujii, Tsuneyo Mimori	2018	21
14	Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis The Journal of Rheumatology ·Keiko Shimamoto, Tomoki� Ito, Yoshio Ozaki, Hideki Amuro, Akihiro Tanaka, Huicong Jiang, Yonsu Son, Muneo Inaba, Shosaku� Nomura	2013	83
15	Effective intravenous immunoglobulin therapy for Churg-Strauss syndrome (allergic granulomatous angiitis) complicated by neuropathy of the eighth cranial nerve: a case report Journal of Medical Case Reports ·Yoshio Ozaki, Akihiro Tanaka, Keiko Shimamoto, Hideki Amuro, Yonsu Son, Tomoki� Ito, Shosaku� Nomura	2012	4
16	Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus Science Translational Medicine ·Roberto Lande, Dipyaman Ganguly, Valeria Facchinetti, Loredana Frasca, Curdin Conrad, Josh Gregorio, Stephan Meller, Georgios Chamilos, Vladyslav Riznyk, Valeria Riccieri, Roland L. Bassett, Hideki Amuro, Shirou Fukuhara, Tomoki� Ito, Yong-Jun Liu, Michel Gilliet Hit paper breakdown →	2011	999
17	Inhibitor of IκB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells Arthritis Research & Therapy ·Rie Miyamoto, Tomoki� Ito, Shosaku� Nomura, Ryuichi Amakawa, Hideki Amuro, T. Müssener, Makoto Ogata, Jesús Román Pérez Balmes, Keiko Shimamoto, Chihiro Yamazaki, Katsuaki Hoshino, Tsuneyasu Kaisho, Shirou Fukuhara	2010	25
18	A case of rheumatoid pericarditis associated with a high IL-6 titer in the pericardial fluid and tocilizumab treatment Modern Rheumatology ·Yoshio Ozaki, Akihiro Tanaka, Keiko Shimamoto, Hideki Amuro, ア-ビブ, Yonsu Son, Tomoki� Ito, Erica Lott, Shosaku� Nomura	2010	12
19	Imidazoquinoline Acts as Immune Adjuvant for Functional Alteration of Thymic Stromal Lymphopoietin-Mediated Allergic T Cell Response The Journal of Immunology ·Yoshitaro Torii, Tomoki� Ito, Ryuichi Amakawa, Hiroyuki Sugimoto, Hideki Amuro, Shaw E. Kittleman, T. Müssener, Makoto Ogata, Takashi Yokoi, Shirou Fukuhara	2008	21
20	Mycobacterium bovis Bacillus Calmette-Guerin suppresses inflammatory Th2 responses by inducing functional alteration of TSLP-activated dendritic cells International Immunology ·Takashi Yokoi, Ryuichi Amakawa, Shaw E. Kittleman, H. Sugimoto, Yoshitaro Torii, Hideki Amuro, Yonsu Son, Teresa Avilés Flor, F. W. Helsby, Tomoki� Ito, S Fukuhara	2008	19

About Hideki Amuro

Hideki Amuro is a scholar working on Rheumatology, Immunology, Hematology, Genetics and Immunology and Allergy, having authored 41 papers that have together received 1.7k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (20 papers), Autoimmune and Inflammatory Disorders Research (10 papers), Systemic Lupus Erythematosus Research (10 papers), Immune Cell Function and Interaction (8 papers), Biosimilars and Bioanalytical Methods (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), T-cell and B-cell Immunology (5 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Immunology (1.1k citations), Rheumatology (639 citations), Immunology and Allergy (134 citations), Hematology (181 citations) and Microbiology (74 citations). Hideki Amuro has collaborated with scholars based in Japan and United States. Frequent co-authors include Tomoki� Ito, Shirou Fukuhara, Stephan Meller, Roberto Lande, Roland L. Bassett, Loredana Frasca, Curdin Conrad, Valeria Riccieri, Michel Gilliet and Yong-Jun Liu. Their work appears in journals such as Arthritis Research & Therapy, Modern Rheumatology, Annals of the Rheumatic Diseases, Lara D. Veeken and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact